Torthaí cuardaigh - Chen‐Ta Chi
- 1 - 4 toradh as 4 á dtaispeáint
-
1
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma de réir Chi-Jung Wu, Pei‐Chang Lee, Ya‐Wen Hung, Chieh-Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Ming‐Chih Hou, Yi‐Hsiang Huang
Foilsithe / Cruthaithe 2022Artigo -
2
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria de réir Ya-Wen Hung, I-Cheng Lee, Chen-Ta Chi, Rheun‐Chuan Lee, Chien-An Liu, Nai‐Chi Chiu, Hsuen-En Hwang, Yee Chao, Ming-Chih Hou, Yi‐Hsiang Huang
Foilsithe / Cruthaithe 2021Artigo -
3
Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy de réir Hsien-Chen Mon, Pei‐Chang Lee, Yi‐Ping Hung, Ya‐Wen Hung, Chi-Jung Wu, Chieh-Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Ming‐Chih Hou, Yi‐Hsiang Huang
Foilsithe / Cruthaithe 2024Artigo -
4
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma de réir Pei‐Chang Lee, Chi-Jung Wu, Ya‐Wen Hung, Chieh Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Yu‐Lun Kuo, Shih-Hsuan Chou, Jiing‐Chyuan Luo, Ming‐Chih Hou, Yi‐Hsiang Huang
Foilsithe / Cruthaithe 2022Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Gastroenterology
Hepatocellular carcinoma
Internal medicine
Medicine
Oncology
Biology
Cancer
Cohort
Immunology
Immunotherapy
16S ribosomal RNA
Bacteria
Biochemistry
Bioinformatics
Biomarker
Confidence interval
Feces
Firmicutes
Genetics
Gut flora
HBsAg
Hazard ratio
Hepatitis B
Hepatitis B virus
Lachnospiraceae
Lenvatinib
Microbiology
Microbiome
Multivariate analysis
Nivolumab